Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 132.0 | 47 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | b-NGF | 97.0 | 67 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 38.0 | 68 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | b-NGF | 32.0 | 51 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 60.5 | 72 | ||||
| RA1869 | 1 | b-NGF | 55.0 | 52 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 32.0 | 51 | ||||
| N2759 | 1 | b-NGF | 35.0 | 51 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 117.0 | 52 | ||||
| RA1931 | 1 | b-NGF | 125.0 | 53 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 43.0 | 36 | ||||
| N2586 | 1 | b-NGF | 40.5 | 36 | |||||||
| 0 | b-NGF | 14.0 | 40 | ||||||||
| 0 | b-NGF | 13.0 | 45 | ||||||||
| 0 | b-NGF | 12.0 | 34 | ||||||||
| 0 | b-NGF | 14.0 | 51 | ||||||||
| 0 | b-NGF | 14.5 | 34 | ||||||||
| 0 | b-NGF | 15.0 | 19 | ||||||||
| RA2159 | 2 | b-NGF | 25.0 | 53 | |||||||
| N2645 | 2 | b-NGF | 261.5 | 52 | |||||||
| RA2708 | 2 | b-NGF | 30.5 | 58 | |||||||
| RA2159 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 28.0 | 48 | ||||
| RA2159 | PH-797804 | 0.6 | uM | 2 | b-NGF | 25.0 | 26 | ||||
| N2645 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 204.5 | 44 | ||||
| N2645 | PH-797804 | 0.6 | uM | 2 | b-NGF | 159.0 | 35 |